A compound of the formula (1) or a pharmaceutically-acceptable salt wherein, for example, A is phenylene or heteroarylene; Y is selected from --C(O)R.sup.2, --C(O)OR.sup.2, --C(O)NR.sup.2R.sup.3, -(1-4C)alkyl [optionally substituted]-(2-4C)alkenyl, --SO.sub.2NR.sup.2R.sup.3, and --S(O).sub.cR.sup.2 (wherein c is 0, 1 or 2); compounds which possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described.

 
Web www.patentalert.com

< Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression

< Pseudounipolar lead for stimulating a digestive organ

> Digestive organ retention device

> Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives

~ 00286